VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3131
ETF rank
โ‚ฌ14.22 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
19,23ย โ‚ฌ
Share price
0.32%
Change (1 day)
4.87%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of December 2025: 0.35%